XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:        
Net (loss) income $ (7,399) $ 3,407 $ 69,482 $ 4,500
Adjustments to reconcile net income to cash flow from operating activities:        
Depreciation and amortization 72,793 16,763 150,966 33,315
Accretion of loan discounts and premiums, net     (5,495) 0
Amortization of deferred financing costs, net     1,824 738
Stock compensation expense     5,178 4,646
Gain on sale of real estate assets, net 0 0 (94,712) 0
Amortization related to derivative instruments     634 608
Casualty (gains) losses, net (5,592) 0 (6,985) 359
Loss from equity method investments 871 0 934 0
Other (income) expense     (736) 0
Changes in assets and liabilities:        
Other assets     6,829 (4,886)
Accounts payable and accrued expenses     (13,775) 3,985
Accrued interest payable     (284) (67)
Other liabilities     (2,273) 54
Cash flow provided by operating activities     111,587 43,252
Cash flows from investing activities:        
Acquisition of real estate properties     (25,957) (139,231)
Investments in unconsolidated real estate entities     (33,519) (10,205)
Return of investment in unconsolidated real estate entities     3,406 0
Disposition of real estate properties, net     155,639 0
Capital expenditures     (29,139) (17,244)
Additions to real estate under development     (20,723) 0
Proceeds from insurance claims     15,462 0
Cash flow provided by (used in) investing activities     65,169 (166,680)
Cash flows from financing activities:        
(Costs) proceeds from issuance of common stock     (960)  
(Costs) proceeds from issuance of common stock       41,551
Proceeds from unsecured credit facility and term loans     81,000 369,500
Unsecured credit facility repayments     (226,000) (234,800)
Mortgage principal repayments     (3,680) (23,456)
Payments for deferred financing costs     (49) (1,205)
Distributions on common stock     (43,425) (24,666)
Distributions to noncontrolling interests     (1,037) (162)
Repurchase of shares related to equity award tax withholding     (5,881) (2,942)
Cash flow (used in) provided by financing activities     (200,032) 123,820
Net change in cash and cash equivalents, and restricted cash     (23,276) 392
Cash and cash equivalents, and restricted cash, beginning of period     65,671 13,615
Cash and cash equivalents, and restricted cash, end of the period 42,395 14,007 42,395 14,007
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet        
Cash and cash equivalents 11,378 7,566 11,378 7,566
Restricted cash 31,017 6,441 31,017 6,441
Total cash, cash equivalents, and restricted cash, end of period $ 42,395 $ 14,007 $ 42,395 $ 14,007